// App-Quantinova.ai

149IN : TTD CONTRIBUTION TO THE PRECISION ONCOLOGY

Researchers

Presenter

  • E. Aranda Aguilar

Principal Investigators

  • N/A

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Circulating tumor cells

  • GTPase Nras

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • Capecitabine

  • Bevacizumab

  • Oxaliplatin

  • Irinotecan

  • Erbitux

  • FOLFOX6

  • FOLFIRI

  • Oxaliplatin, 5-fluorouracil and folic acid

  • Capecitabine and oxaliplatin

  • Adrucil injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved